Structure-based design of potent, conformationally constrained Smac mimetics

被引:134
作者
Sun, HY
Nikolovska-Coleska, Z
Yang, CY
Xu, L
Liu, ML
Tomita, Y
Pan, HG
Yoshioka, Y
Krajewski, K
Roller, PP
Wang, SM
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[4] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
[5] Natl Canc Inst Frederick, Med Chem Lab, NIH, Ft Detrick, MD 21702 USA
关键词
D O I
10.1021/ja047438+
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A successful structure-based design and synthesis of a class of highly potent conformationally constrained Smac mimetics is described. The most potent compound has a Ki value of 25 nM binding to the XIAP BIR3 protein and is 23 times more potent than natural Smac peptides. These potent Smac mimetics can serve as powerful chemical and pharmacological tools to further elucidate the role of Smac and its cellular binding partners in apoptosis regulation and may be developed as a new class of anti-cancer drugs. Copyright © 2004 American Chemical Society.
引用
收藏
页码:16686 / 16687
页数:2
相关论文
共 14 条
[1]  
Amt C R., 2002, J Biol Chem, V277, P44236
[2]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[3]   Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo [J].
Fulda, S ;
Wick, W ;
Weller, M ;
Debatin, KM .
NATURE MEDICINE, 2002, 8 (08) :808-815
[4]   A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death [J].
Li, L ;
Thomas, RM ;
Suzuki, H ;
De Brabander, JK ;
Wang, XD ;
Harran, PG .
SCIENCE, 2004, 305 (5689) :1471-1474
[5]   Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain [J].
Liu, ZH ;
Sun, CH ;
Olejniczak, ET ;
Meadows, RP ;
Betz, SF ;
Oost, T ;
Herrmann, J ;
Wu, JC ;
Fesik, SW .
NATURE, 2000, 408 (6815) :1004-1008
[6]   Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XLAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database [J].
Nikolovska-Coleska, Z ;
Xu, L ;
Hu, ZJ ;
Tomita, Y ;
Li, P ;
Roller, PP ;
Wang, RX ;
Fang, XL ;
Guo, RB ;
Zhang, MC ;
Lippman, ME ;
Yang, DJ ;
Wang, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2430-2440
[7]   Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization [J].
Nikolovska-Coleska, Z ;
Wang, RX ;
Fang, XL ;
Pan, HG ;
Tomita, Y ;
Li, P ;
Roller, PP ;
Krajewski, K ;
Saito, NG ;
Stuckey, JA ;
Wang, SM .
ANALYTICAL BIOCHEMISTRY, 2004, 332 (02) :261-273
[8]   Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer [J].
Oost, TK ;
Sun, CH ;
Armstrong, RC ;
Al-Assaad, AS ;
Betz, SF ;
Deckwerth, TL ;
Ding, H ;
Elmore, SW ;
Olejniczak, ET ;
Oleksijew, A ;
Oltersdorf, T ;
Rosenberg, SH ;
Shoemaker, AR ;
Tomaselli, KJ ;
Zou, H ;
Fesik, SW .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) :4417-4426
[9]   A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis [J].
Srinivasula, SM ;
Hegde, R ;
Saleh, A ;
Datta, P ;
Shiozaki, E ;
Chai, JJ ;
Lee, RA ;
Robbins, PD ;
Fernandes-Alnemri, T ;
Shi, YG ;
Alnemri, ES .
NATURE, 2001, 410 (6824) :112-116
[10]   Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site [J].
Sun, HY ;
Nikolovska-Coleska, Z ;
Yang, CY ;
Xu, L ;
Tomita, Y ;
Krajewski, K ;
Roller, PP ;
Wang, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4147-4150